4.8 Article

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies

Ilaria Poggiolini et al.

Summary: The study aimed to assess the diagnostic value of CSF alpha-synuclein RT-QuIC quantitative parameters in regard to disease progression, stratification, and conversion in synucleinopathies. The results showed that alpha-synuclein RT-QuIC adds value in diagnosing Parkinson's disease and may provide a way to distinguish variations within Parkinson's disease phenotype. The assay also showed potential as an early biomarker detecting synucleinopathy in idiopathic REM sleep behaviour disorder patients prior to conversion.
Article Clinical Neurology

Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson's disease

Evgeniia Lobanova et al.

Summary: The aggregation of alpha-synuclein is important in the development of Parkinson's disease. Studying the aggregates in biofluids such as cerebrospinal fluid (CSF) and serum can provide insights into disease mechanisms and potential diagnostic markers.
Article Clinical Neurology

Detection of neuron-derived pathological α-synuclein in blood

Annika Kluge et al.

Summary: To date, no reliable clinically applicable biomarker has been established for Parkinson's disease. Our results suggest that a blood test for Parkinson's disease using neuronal extracellular vesicles may be possible.
Article Biology

Quantum-dot-labeled synuclein seed assay identifies drugs modulating the experimental prion-like transmission

Yukio Imamura et al.

Summary: In this study, alpha-synuclein preformed fibrils (PFF) were labeled with quantum dots, allowing for the visualization of their movement in brain tissue slices. The trafficking of alpha-syn seeds was found to depend on fast axonal transport, while seed spreading was dependent on endocytosis and neuronal activity. Pharmacological effects on alpha-syn seed spreading were also observed, with drugs such as riluzole effectively reducing seed spread both in vitro and in vivo.

COMMUNICATIONS BIOLOGY (2022)

Article Neurosciences

Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories

Connor Bargar et al.

Summary: The study demonstrates that OM-alpha Syn(D) could serve as a novel biomarker for the accurate clinical diagnoses of PD, MSA-P, and MSA-C. Additionally, alpha Syn_RT-QuIC is a reliable assay that can distinguish between MSA-P and MSA-C patients, potentially leading to advancements in patient stratification for emerging pharmacological treatments and clinical trials.

MOLECULAR NEURODEGENERATION (2021)

Article Clinical Neurology

Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study

Alex Iranzo et al.

Summary: The study found that RT-QuIC can detect misfolded alpha-synuclein in the CSF of patients with IRBD with both high sensitivity and specificity, indicating that detection of alpha-synuclein may serve as an early marker for Parkinson's disease and dementia with Lewy bodies.

LANCET NEUROLOGY (2021)

Article Biochemistry & Molecular Biology

Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy

Sofia Lovestam et al.

Summary: The study found that the structures of seeded assemblies differ from those of the seeds, indicating that additional unknown factors may play a role in the propagation of seeds. Identification of these factors is crucial for understanding the prion-like spreading of alpha-synuclein proteinopathies.

FEBS OPEN BIO (2021)

Article Clinical Neurology

Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder

Ambra Stefani et al.

Summary: RT-QuIC detection of alpha-synuclein aggregates in olfactory mucosa showed a linkage between alpha-synuclein pathology and olfactory dysfunction in patients with isolated RBD and Parkinson's disease, indicating a potential for early detection and preventive therapies.
Article Clinical Neurology

α-Synuclein Deposition in Sympathetic Nerve Fibers in Genetic Forms of Parkinson's Disease

Risa Isonaka et al.

Summary: This study compared the intraneuronal deposition of alpha-syn in common and rare genetic forms of Parkinson's disease, finding variations in alpha-syn deposition based on genotype. Patients with certain genetic mutations showed substantial intraneuronal alpha-syn deposition, while those with biallelic PRKN mutations did not.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies

Marcello Rossi et al.

Summary: The CSF alpha-syn RT-QuIC assay is a robust biomarker for prodromal DLB, accurately identifying patients with MCI-LB with high sensitivity and specificity, with consistent results between two cohorts.

NEUROLOGY (2021)

Article Clinical Neurology

Diagnostic Value of the CSF a-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies

Marcello Rossi et al.

Summary: The CSF α-synuclein RT-QuIC is a robust biomarker for prodromal DLB, showing consistent accuracy for MCI-LB across two cohorts. Some patients with MCI-AD also tested positive, indicating potential underlying LB pathology.

NEUROLOGY (2021)

Article Clinical Neurology

Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies

Daniela Perra et al.

Summary: The study examined the diagnostic accuracy of alpha-synuclein real-time quaking-induced conversion assay in detecting alpha-synuclein in olfactory mucosa and CSF of patients with suspected dementia with Lewy bodies. The results suggest that this approach could optimize clinical diagnosis and potentially improve concordance with clinical diagnosis.

BRAIN COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy

Mohammad Shahnawaz et al.

NATURE (2020)

Article Clinical Neurology

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease

Chun-Wei Chang et al.

FRONTIERS IN NEUROLOGY (2020)

Article Clinical Neurology

Seeding variability of different alpha synuclein strains in synucleinopathies

Niccolo Candelise et al.

ANNALS OF NEUROLOGY (2019)

Article Clinical Neurology

Neuromelanin or DaT-SPECT: which is the better marker for discriminating advanced Parkinson's disease?

A. Okuzumi et al.

EUROPEAN JOURNAL OF NEUROLOGY (2019)

Article Clinical Neurology

Oral and intravenous transmission of α-synuclein fibrils to mice

Stephanie Lohmann et al.

ACTA NEUROPATHOLOGICA (2019)

Review Clinical Neurology

Multiple System Atrophy: Recent Developments and Future Perspectives

Wassilios G. Meissner et al.

MOVEMENT DISORDERS (2019)

Article Neurosciences

Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment

Ayami Okuzumi et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)

Article Geriatrics & Gerontology

The Luxembourg Parkinson's Study: A Comprehensive Approach for Stratification and Early Diagnosis

Geraldine Hipp et al.

FRONTIERS IN AGING NEUROSCIENCE (2018)

Article Clinical Neurology

Plasma α-synuclein predicts cognitive decline in Parkinson's disease

Chin-Hsien Lin et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)

Review Clinical Neurology

Neuropathology of Genetic Synucleinopathies With Parkinsonism: Review of the Literature

Susanne A. Schneider et al.

MOVEMENT DISORDERS (2017)

Review Biochemistry & Molecular Biology

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

Yvette C. Wong et al.

NATURE MEDICINE (2017)

Review Clinical Neurology

Impact of multiple pathologies on the threshold for clinically overt dementia

Alifiya Kapasi et al.

ACTA NEUROPATHOLOGICA (2017)

Article Clinical Neurology

Identification of novel biomarkers for Parkinson's disease by metabolomic technologies

Taku Hatano et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

Article Clinical Neurology

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies

Graham Fairfoul et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)

Review Clinical Neurology

MDS clinical diagnostic criteria for Parkinson's disease

Ronald B. Postuma et al.

MOVEMENT DISORDERS (2015)

Review Clinical Neurology

Neuropathology underlying clinical variability in patients with synucleinopathies

Glenda M. Halliday et al.

ACTA NEUROPATHOLOGICA (2011)

Review Clinical Neurology

Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease

Claire L. Tomlinson et al.

MOVEMENT DISORDERS (2010)

Article Clinical Neurology

Incidence and remaining lifetime risk of Parkinson disease in advanced age

Jane A. Driver et al.

NEUROLOGY (2009)

Article Clinical Neurology

Second consensus statement on the diagnosis of multiple system atrophy

S. Gilman et al.

NEUROLOGY (2008)

Article Clinical Neurology

The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy

P. H. Lee et al.

JOURNAL OF NEURAL TRANSMISSION (2006)

Article Biochemistry & Molecular Biology

Cysteine misincorporation in bacterially expressed human α-synuclein

M Masuda et al.

FEBS LETTERS (2006)